日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control

克服早期乳腺癌预防试验的挑战:巴泽多昔芬和结合雌激素与等待名单对照组的比较

Fabian, Carol J; Mudaranthakam, Dinesh Pal; Gajewski, Byron; Young, Kate; Winblad, Onalisa; Khan, Seema A; Garber, Judy E; Esserman, Laura J; Yee, Lisa D; Nye, Lauren; Powers, Kandy R; Ranallo, Lori; Kreutzjans, Amy L; Pittman, Krystal; Altman, Christy; Metheny, Trina; Zelenchuk, Adrian; Komm, Barry S; Kimler, Bruce F

Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer

一项针对绝经前乳腺癌高危女性的木脂素开环异落叶松脂素二葡萄糖苷的随机IIB期试验

Fabian, Carol J; Khan, Seema A; Garber, Judy E; Dooley, William C; Yee, Lisa D; Klemp, Jennifer R; Nydegger, Jennifer L; Powers, Kandy R; Kreutzjans, Amy L; Zalles, Carola M; Metheny, Trina; Phillips, Teresa A; Hu, Jinxiang; Koestler, Devin C; Chalise, Prabhakar; Yellapu, Nanda Kumar; Jernigan, Cheryl; Petroff, Brian K; Hursting, Stephen D; Kimler, Bruce F

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

良性乳腺组织和血清风险生物标志物的有利调节与绝经后妇女体重减轻 10% 以上相关

Fabian Carol J, Kimler Bruce F, Donnelly Joseph E, Sullivan Debra K, Klemp Jennifer R, Petroff Brian K, Phillips Teresa A, Metheny Trina, Aversman Sonya, Yeh Hung-Wen, Zalles Carola M, Mills Gordon B, Hursting Stephen D

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside

木脂素类化合物 secoisolariciresinol 二糖苷可降低高危女性良性乳腺组织中的 Ki-67 水平。

Fabian, Carol J; Kimler, Bruce F; Zalles, Carola M; Klemp, Jennifer R; Petroff, Brian K; Khan, Qamar J; Sharma, Priyanka; Setchell, Kenneth D R; Zhao, Xueheng; Phillips, Teresa A; Metheny, Trina; Hughes, Jennifer R; Yeh, Hung-Wen; Johnson, Karen A